Journal List > Immune Netw > v.20(1)

e1 Coalition Forces of Immunologists and Oncologists for Defeating Cancer
Eui-Cheol Shin
Immune Netw. 2020;20(1):e1.  Published online 2020 February 20    DOI: http://dx.doi.org/10.4110/in.2020.20.e1
[Article]   [PDF]   [ePub]   
e2 Re-defining T-Cell Exhaustion: Subset, Function, and Regulation
Se Jin Im, Sang-Jun Ha
Immune Netw. 2020;20(1):e2.  Published online 2020 February 20    DOI: http://dx.doi.org/10.4110/in.2020.20.e2
[Article]   [PDF]   [ePub]   
e3 Co-Stimulatory Receptors in Cancers and Their Implications for Cancer Immunotherapy
Seongju Jeong, Su-Hyung Park
Immune Netw. 2020;20(1):e3.  Published online 2020 February 7    DOI: http://dx.doi.org/10.4110/in.2020.20.e3
[Article]   [PDF]   [ePub]   
e4 Regulatory T Cells in Tumor Microenvironment and Approach for Anticancer Immunotherapy
Jung-Ho Kim, Beom Seok Kim, Sang-Kyou Lee
Immune Netw. 2020;20(1):e4.  Published online 2020 February 11    DOI: http://dx.doi.org/10.4110/in.2020.20.e4
[Article]   [PDF]   [ePub]   
e5 Heterogeneity of Human γδ T Cells and Their Role in Cancer Immunity
Hye Won Lee, Yun Shin Chung, Tae Jin Kim
Immune Netw. 2020;20(1):e5.  Published online 2020 February 14    DOI: http://dx.doi.org/10.4110/in.2020.20.e5
[Article]   [PDF]   [ePub]   
e6 IL-17-Producing Cells in Tumor Immunity: Friends or Foes?
Da-Sol Kuen, Byung-Seok Kim, Yeonseok Chung
Immune Netw. 2020;20(1):e6.  Published online 2020 February 7    DOI: http://dx.doi.org/10.4110/in.2020.20.e6
[Article]   [PDF]   [ePub]   
e7 Far Beyond Cancer Immunotherapy: Reversion of Multi-Malignant Phenotypes of Immunotherapeutic-Resistant Cancer by Targeting the NANOG Signaling Axis
Se Jin Oh, Jaeyoon Lee, Yukang Kim, Kwon-Ho Song, Eunho Cho, Minsung Kim, Heejae Jung, Tae Woo Kim
Immune Netw. 2020;20(1):e7.  Published online 2020 January 20    DOI: http://dx.doi.org/10.4110/in.2020.20.e7
[Article]   [PDF]   [ePub]   
e8 Peripheral blood immune cell-based biomarkers in anti-PD-1/PD-L1 therapy
Kyung Hwan Kim, Chang Gon Kim, Eui-Cheol Shin
Immune Netw. 2020;20(1):e8.  Published online 2020 February 10    DOI: http://dx.doi.org/10.4110/in.2020.20.e8
[Article]   [PDF]   [ePub]   
e9 Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors
Juwhan Choi, Sung Yong Lee
Immune Netw. 2020;20(1):e9.  Published online 2020 February 17    DOI: http://dx.doi.org/10.4110/in.2020.20.e9
[Article]   [PDF]   [ePub]   
e10 Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives
Sun Min Lim, Min Hee Hong, Hye Ryun Kim
Immune Netw. 2020;20(1):e10.  Published online 2020 January 27    DOI: http://dx.doi.org/10.4110/in.2020.20.e10
[Article]   [PDF]   [ePub]   
e11 Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest?
Hye Won Lee, Kyung Joo Cho, Jun Yong Park
Immune Netw. 2020;20(1):e11.  Published online 2020 February 17    DOI: http://dx.doi.org/10.4110/in.2020.20.e11
[Article]   [PDF]   [ePub]   
Articles from Immune Network are provided here courtesy of The Korean Association of Immunobiologists